Article Text

Download PDFPDF
Introduction of Penthrox to the defence medical services: early findings
  1. Stuart McPhail1,2,
  2. A Thornback3,
  3. D Ochiltree3,
  4. M E R Marsden4,5 and
  5. A Kumar6
  1. 1Department of Anaesthesia, Torbay Hospital, Devon, UK
  2. 2Department of Health and Community Sciences, University of Exeter, Exeter, UK
  3. 3Institute of Naval Medicine, Gosport, UK
  4. 4Academic Department of Military Surgery and Trauma, RCI, Birmingham, UK
  5. 5Centre for Trauma Sciences, Queen Mary University of London, London, UK
  6. 6Academic Department of Military Anaesthesia, RCI, UK Defence Medical Services, Birmingham, UK
  1. Correspondence to Lt Col A Kumar, Defence Medical Services, Lichfield, UK; Alexander.kumar651{at}mod.gov.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Inhaled methoxyflurane has been used in the civilian prehospital setting to treat pain for several decades.1 Despite having attributes that are well suited to the deployed environment,2 its introduction to military settings appears to be more recent and, to our knowledge, there is only one published study in this setting.3 We aimed to explore the experience of clinicians administering methoxyflurane via the Penthrox inhalator device (Galen, UK), following its introduction to the UK Defence Medical Services (DMS) in 2021.

Between 22 May 2022 and 3 March 2023, DMS clinicians were invited to complete a survey using a web-based form. The survey was distributed electronically and advertised at educational events. Of a total of 48 reported administration events, most (69%) were provided by doctors with the remainder delivered by other military healthcare providers. All …

View Full Text

Footnotes

  • X @maxmarsden83

  • Correction notice Thia articles has been corrected since it first published. Affiliations for Stuart McPhail have been changed from 1) Academic Department of Military Anaesthesia, RCI, UK Defence Medical Services, Birmingham, UK to 1) Department of Anaesthesia, Torbay Hospital, Devon, UK, 2) Department of Health and Community Sciences, University of Exeter, Exeter, UK.

  • Contributors AK, SM, DO and AT conceived the study. SM, AT and DO developed and carried out the study and initial data analysis. MERM completed subsequent analysis. SM drafted the manuscript. All authors commented on, and contributed to, the final draft. AK acts as the guarantor for this work.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.